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A B S T R A C T
A special interest group (SIG) entitled "Older Adults with ASD: The Consequences of Aging" was
held at the International Society for Autism Research (INSAR) annual meetings in 2016 and
2017. The SIG and subsequent meetings brought together, for the first time, international dele-
gates who were members of the autistic community, researchers, practitioners and service pro-
viders. Based on aging autism research that is already underway in UK, Europe, Australia and
North America, discussions focussed on conceptualising the parameters of aging when referring
to autism, and the measures that are appropriate to use with older adults when considering
diagnostic assessment, cognitive factors and quality of life in older age. Thus, the aim of this SIG
was to progress the research agenda on current and future directions for autism research in the
context of aging. A global issue on how to define 'aging' when referring to ASD was at the
forefront of discussions. The ‘aging’ concept can in principle refer to all developmental transi-
tions. However, in this paper we focus on the cognitive and physical changes that take place from
mid-life onwards. Accordingly, it was agreed that aging and ASD research should focus on adults
over the age of 50 years, given the high rates of co-occurring physical and mental health concerns
and increased risk of premature death in some individuals. Moreover, very little is known about
the cognitive change, care needs and outcomes of autistic adults beyond this age. Discussions on
the topics of diagnostic and cognitive assessments, and of quality of life and well-being were
explored through shared knowledge about which measures are currently being used and which
background questions should be asked to obtain comprehensive and informative developmental
and medical histories. Accordingly, a survey was completed by SIG delegates who were re-
presentatives of international research groups across four continents, and who are currently
conducting studies with older autistic adults. Considerable overlap was identified across different
research groups in measures of both autism and quality of life, which pointed to combining data
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T
and shared learnings as the logical next step. Regarding the background questions that were
asked, the different research groups covered similar topics but the groups differed in the way
these questions were formulated when working with autistic adults across a range of cognitive
abilities. It became clear that continued input from individuals on the autism spectrum is im-
portant to ensure that questionnaires used in ongoing and future are accessible and under-
standable for people across the whole autistic spectrum, including those with limited verbal
abilities.
1. Introduction
Autism Spectrum Disorder (ASD)1 has for many decades been known as a lifelong neurodevelopmental disorder, which may have
profound effects on intellectual ability and psychological functioning, general ability, and life outcomes (Howlin et al., 2004; Howlin
et al., 2013; Howlin et al., 2014). However, autism research has to date largely neglected the life outcomes and trajectories for older
adults diagnosed with the condition (Michael, 2016; Mukaetova-Ladinska et al., 2012; Smith et al., 2012). This has led to recent
reports attempting to identify priorities for research on aging and ASD (e.g. Happé & Charlton, 2011; Howlin et al., 2015; Damiano
et al., 2014). Several other co-existing conditions, such as anxiety, depression, Attention Deficit Hyperactivity Disorder (ADHD) and
Obsessive-Compulsive Disorder (OCD; Lever & Geurts, 2016) are associated with their own sets of psychological difficulties that can
affect general wellbeing and autonomous living (Hofvander et al., 2009; Kats et al., 2013). All these factors converge on several key
areas that point to the need for better understanding of the experiences of autistic individuals as they grow older. Moreover, long-
term mental health difficulties, such as depression, are known to be associated with cognitive difficulties in typical aging (McClintock
et al., 2010), and with increased risk of neurocognitive disorders (i.e. dementia; Bauman, 2010) in the general population (Evans &
Mottram, 2000). The findings from many studies in the typical aging literature suggest that cognitive aging can be observed after 50
years of age with declines observed in processing speed (Salthouse, 1996); attention (McCabe et al., 2010), metacognitive ability
(Mäntylä et al., 2010), executive functions (Craik & Bialystok, 2006; Friedman & Miyake, 2017), memory (Craik & Byrd, 1982;
Rabbitt, 2016) and general intellectual ability (Salthouse, 2004; Anderson & Craik, 2017; and see Hedden & Gabrieli, 2004 for review
of lifespan changes and stability). More broadly, during the course of aging, changes in the domains of memory, executive function,
and fluid intelligence affect psychological functioning and well-being. This includes functional skills for independent daily living and
life management, including the ability to perform more demanding activities such as employment, planning skills, spatial orientation
and navigation, taking one's medication and even remembering a doctor's appointment or someone's name (McDaniel & Einstein,
2000). In this respect, age-related cognitive decline can have far-reaching and devastating effects on an individual’s general func-
tioning and independence, leading to social isolation and poorer quality of life (Crook et al., 1986; Hedden & Gabrieli, 2004;
Salthouse et al., 2003; Salthouse, 2004; Woods et al., 2015). Further, neurocognitive research involving the study of the interaction
between the changes in the nervous system and changes in brain regions may provide clues to the cognitive mechanisms that underlie
how individuals learn and process information. For instance, the impairments observed in cognitive functioning within certain
clinical groups are similar to those observed in persons with brain trauma or developmental disorders (Cappelletti et al., 2014;
Dempster, 1992). These similarities indicate that particular brain regions are be implicated in learning and memory across the
lifespan. For instance, frontal brain regions (associated with executive function) and the hippocampus and related structures of the
medial temporal lobe (associated with memory) have been shown to decline in volume and functional connectivity with increasing
age (e.g. Raz et al., 2005; Craik & Rose, 2012a, Craik & Rose, 2012b; Ferreira et al., 2016) – a picture that corresponds to the
cognitive and brain profiles of patients with amnestic and dementia pathologies (Hedden & Gabrieli, 2004). For individuals on the
autism spectrum, a similar profile has been identified, in relation to atypical functional connectivity between associated brain regions
at various developmental stages (e.g. Boucher et al., 2012; Just et al., 2012), including middle-older age (40–65 years; Braden et al.,
2015). In turn, these brain differences in autistic individuals are accompanied by selective cognitive difficulties, such as executive
function and memory (Boucher et al., 2012; Braden et al., 2015; Hill, 2004; but see Mottron & Burack, 2001). The parallels that can
be drawn between cognitive difficulties in younger autistic individuals and the similar profile of difficulties seen in typical age-related
cognitive decline, suggests that autistic individuals may present as prematurely cognitively old (Bowler, 2007). If true, then these
findings highlight important considerations of how growing older might affect the cognitive abilities and functioning of older autistic
adults and whether early developmental profiles present an increased risk of cognitive decline associated with dementia and co-
existing mental health conditions (Braden et al., 2015; Croen et al., 2015; but see Oberman & Pascual-Leone, 2014).
The risk of onset of dementia, including Alzheimer’s disease which is the most common (62%) cause of dementia, increases
dramatically with older age (Lewis et al., 2014; Prince et al., 2014). An estimated 2% of adults aged 65–69 years have dementia
1 The diagnostic term autism spectrum disorder (ASD) follows the DSM-5 guidelines (APA, 2015) and includes autism, autism spectrum and
Asperger’s diagnoses that were previously classified under DSM-III and DSM-IV-TR guidelines. The term 'autism' can be used both as a general term
for what we think of as the essential core of ASD, or it can be a clinical sign or feature of individuals with ASD (as in 'autistic aloneness' or showing
signs of autism - i.e. withdrawal from or reluctance to engage in two-way social interaction). For clarity of expression, the terms ASD and autism are
used in this manuscript to denote the above descriptions. When describing individuals on the autism spectrum, we acknowledge that many different
terms are used by the autism community, as the preferred language used by autistic people and their families, and professionals (Kenny, Hattersley,
Molins et al., 2016). In this paper, we use identify-first terminology (i.e. autistic individual; autistic adult etc.).
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(1.8% female; 1.5% male), increasing to 25% (men) to 33% (women) by age 85 years or older (Stuart-Hamilton, 2006, p. 197; Lewis
et al., 2014; Prince et al., 2014) – some research suggests even higher risks for Alzheimer’s disease in almost half of all adults in older
age (85+ years; Bishop et al., 2010). The various forms of dementia are associated with fronto-temporal lobe dysfunction – the
domains associated with executive and memory functions (Bishop et al., 2010) – and are thought to exacerbate the effect of age-
related cognitive decline and poor quality of life (Knapp et al., 2007; Lewis et al., 2014). In ASD, little is known of the risk of dementia
in older age. One study (Croen et al., 2015) reported prevalence rates of 1.9% (men) to 3.2% (women), for dementia in autistic adults.
Another study has speculated that cognitive “hyperplasticity” (Oberman & Pascual-Leone, 2014, p.341), which could explain the
cognitive and behavioural profiles seen in early development (Oberman & Pascual-Leone, 2008), may offer protection from dementia
in older age when plasticity is typically reduced. However, the possible factors associated with dementia-related protection or risk in
ASD are under-researched and still poorly understood (Wright et al., 2016). Consequently, because very little research has included
older autistic adults, much less is known about how the process of aging affects the quality of life of autistic individuals and the need
for long-term care (Happé & Charlton, 2011; Howlin et al., 2015; Mukaetova-Ladinska et al., 2012). We aimed to address the gap in
knowledge by bringing together, for the first time, an international consortium of researchers, professionals and autistic adults to
discuss the issues related to aging and autism, with implications for future research and clinical applications.
Based on ongoing work concerning the cognitive changes associated with aging in ASD and their impact on quality of life (e.g.,
Braden et al., 2017; Lever & Geurts, 2015; Powell et al., 2017; Roestorf & Bowler, 2016; Roestorf, Howlin et al., 2018; van Heijst &
Geurts, 2015), a series of Special Interest Group (SIG) meetings was held at the 2016 and 2017 annual meetings for the International
Society for Autism Research (INSAR). These were co-led by the first and last author of the present article. The SIG objectives focused
on three priorities for Aging and ASD derived from recent reports (e.g. “Getting On Policy Report”, National Autistic Society, 2008;
Pellicano, Dinsmore, & Charman, 2014a, Pellicano, Dinsmore, & Charman, 2014b; “Autistica’s Research Strategy 2015-20″, Autistica,
2014), which were:
(1) Later life autistic traits and diagnosis of ASD: for earlier referral and/or interventions, better diagnostic tools, and post-diagnostic
support of autistic adults;
(2) Cognitive aging in ASD: for a better understanding of the age-related cognitive changes associated with aging in ASD and potential
risk factors for cognitive declines associated with dementia;
(3) Treatment and care of older adults: with respect to general wellbeing, physical, and mental health across the autistic adult’s
lifespan.
These priorities were provided as starter points for a more in-depth discussion to determine how the autism research community
can develop more collaborative research in order to maximise validity and generalisability of findings and conclusions. Delegates in
the first SIG meeting (N=53) included representatives from nine countries (UK, Netherlands, Italy, Norway, Denmark, USA, Canada,
Australia, Taiwan). In that meeting, which was held at INSAR Baltimore, USA in May 2016, delegates were asked to discuss the above
three priorities in small groups and to identify and report back on two key points related to them. Delegates elected to participate in
one of the three discussion groups related to the above themes, based on their specific area of research interest. The discussion points
for each priority were: (a) to identify the primary question to be addressed, potentially in a collaborative research effort; (b) to discuss
one single challenge that needed to be overcome when studying this specific age group and provide a potential solution to this
challenge. The main outcomes from these discussion groups are reported below.
2. Global issues about aging and ASD
An issue that transcended the priority areas was the question of how to define 'aging' when referring to ASD. Whilst it was
acknowledged that aging is a broad concept that spans developmental issues relating to the transition from child to adulthood to
considerations of care and cognitive change in individuals older than 65 years, it was also agreed that research on aging in autism
should focus on individuals over 50 years of age. The consensus was that this relatively arbitrary boundary is appropriate, especially
as autism is associated with premature death in some cases (mean age 54 years; Hirvikoski et al., 2016) which may be accelerated by
a wide range of co-existing medical conditions (Croen et al., 2015; Zerbo et al., 2018). Thus, recent research has highlighted greater
co-occurring health conditions and mental health needs in ASD compared to the general population (Hirvikoski et al., 2016; Fortuna
et al., 2016; Happé et al., 2016; and see Lever & Geurts, 2016). Moreover, relatively few have access to appropriate services in
adulthood and across their lifespan (Wright et al., 2016). The co-occurrence of one or more physical or mental health conditions is
reported in at least 50–84% of autistic individuals (Hirvikoski et al., 2016; Hofvander et al., 2009; Lever & Geurts, 2016) but little is
known about the health and social support services available for older autistic adults who may need continued support related to
autistic traits, co-occurring mental health difficulties or daily living skills (Fortuna et al., 2016; Hirvikoski et al., 2016; Nicolaidis
et al., 2014; Seltzer et al., 2004; and see Wright et al., 2016). The cumulative effect of long-term psychiatric co-existing conditions on
cognitive functions and quality of life is largely unknown (Howlin & Moss, 2012; Howlin et al., 2015; Kats et al., 2013). In addition,
the use of pharmacological treatments for co-existing conditions may further affect cognitive difficulties, such as memory (Joss et al.,
2003). These factors pose particular challenges for autistic individuals as they grow older and may be exacerbated in the case of those
individuals who are unable to live independently, since support from family members is likely to be reduced as parent caregivers
themselves approach old age and end of life (Howlin et al., 2015). The implications of these factors are that many autistic adults will
continue to require social care support across the lifespan (Parr, 2016; D’Astous et al., 2016; Howlin et al., 2013). Moreover, there is a
growing awareness of the risk factors associated with multiple co-occurring complex health conditions and reduced life expectancy in
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ASD, with potentially greater risks for individuals with impaired cognitive ability, including those with intellectual disabilities (ID)
and epilepsy (Hirvikoski et al., 2016; Mouridsen et al., 2008). Consequently, as co-existing ID is an important factor in the context of
premature death (Hirvikoski et al., 2016), future discussions are needed to determine how this might impact on the suggested old age
boundary for aging and autism research.
2.1. Topic (1): Late life autistic traits and diagnosis of ASD
2.1.1. Key questions
Anecdotes from autistic self-advocates and practitioners confirmed that receiving a diagnosis of ASD in later life was a life
changing event. Clinicians face multiple challenges in identifying the clinical features of autism in older adults, especially in the ways
these may differ from the symptoms shown by a younger autistic individual and across a range of abilities. This can result in
undiagnosed older adults failing to be identified by social or healthcare services (Brugha et al., 2011; Wright et al., 2016). The key
question that emerged from this discussion topic was: 'What does ASD look like in older individuals?' This led to a secondary question:
'What questions should be asked to obtain appropriate background information about medical and developmental histories in older autistic
adults in order to reach a reliable diagnosis?'.
2.1.2. Challenges to addressing key question(s) and potential solutions
A major issue associated with research on aging and autism is the participation of the full spectrum of older autistic individuals.
Some individuals may be unable to take part in research because of limited verbal or cognitive ability. Thus, a collaborative effort is
needed by aging and autism researchers to ensure that individuals with limited verbal skills can be included in related research, and
to adequately address the research priorities of autistic adults, their families and partners (Autistica, 2014; Pellicano, Dinsmore, &
Charman, 2014a, Pellicano, Dinsmore, & Charman, 2014b; Warner et al., 2018; and see Autistica, 2018). In others, social isolation
may result in their failing to be aware of requests for research participation; still others may have been undiagnosed or misdiagnosed
in earlier life and therefore never have received an ASD diagnosis or may not present themselves as autistic. This raises further
questions about the factors that prevent older adults from receiving a diagnosis. These may include 'masking' of symptoms, which
seems particularly prevalent in women (Lai et al., 2015); the degree of co-existing conditions and autism-related symptoms, which
may fall under the threshold of some diagnostic methods (Happé & Charlton, 2011; Roestorf, Gaigg, Williams & Bowler, 2018) and
differences or strengths in cognitive abilities, educational attainment and social-cognitive function (2014, Howlin et al., 2013) that
may enable or inhibit individuals from participation in research (Pellicano, Dinsmore, & Charman, 2014a, Pellicano, Dinsmore, &
Charman, 2014b). SIG delegates also recommended that healthcare professionals need to be better informed of the age-related
conditions and cognitive changes that can occur at various life stages, and how these changes may specifically affect older autistic
adults.
2.2. Topic (2): Cognitive aging, decline, and dementia risk
2.2.1. Key questions to ask
The discussion centred around how researchers and clinicians could reach consensus on the cognitive assessment measures
appropriate for older autistic adults, given wide differences in verbal and intellectual ability across the autism spectrum. The primary
question that emerged from this discussion topic was: 'How do we define the core assessments of basic cognitive function, that are
appropriate for autistic individuals across the spectrum of ability and across the lifespan?' This led to a second question: 'How do these
measures need to be adapted for reliable assessments that are age-appropriate, ability-specific and gender-relevant?'.
The question of cultural relevance was raised in relation to race/ethnicity and how future assessments are adapted to culturally
specific requirements. Regarding cultural diversity, it was suggested that shared insights from the international consortium of re-
searchers may to some extent facilitate this knowledge. However, more work is needed to understand the scope of implications for the
collection of sensitive personal information in line with data protection regulations of each country or region.
2.2.2. Challenges to address key question(s) and potential solutions
The challenges to reaching a consensus on measurement include identifying measures that are sensitive to age-related changes
and can characterise the diagnostic differences on the autism spectrum whilst remaining appropriate for use with autistic individuals
with and without co-existing ID. A key consideration includes methods of identifying ‘missing groups’ of individuals with autism who
do not self-refer for research and who may be lost in the community. These may include, for example, individuals over the age of 21
years who are no longer in social or health-related services; those with co-existing ID; or older autistic individuals in residential care.
Moreover, measures need to be robust to practice effects when tracking long-term outcomes in longitudinal research. Issues were also
raised around appropriate referral to healthcare services for individuals with multiple physical and mental health conditions, and the
need to establish a better understanding of the long-term effects of pharmacological treatments on cognitive decline in later life. It
was recognised that insights from related work on the age-related cognitive changes in typical development (i.e. gerontology; Wright
et al., 2016) and neuropsychological conditions (e.g. schizophrenia, Down’s syndrome, Parkinson’s; e.g. Coppus et al., 2006; Croen
et al., 2015; Starkstein et al., 2015a; Starkstein et al., 2015b) may provide clues for what could be expected of aging in ASD. Such
research is also important for identifying the potential risk factors for age-related cognitive impairments in later life and markers of
cognitive decline associated with dementia (Coppus et al., 2006; Croen et al., 2015). The consensus was that there was a need for
future work to define a (small) set of cognitive measures based mainly on current studies that already focus on cognitive aging (Lever
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& Geurts, 2015; Powell et al., 2017; Roestorf & Bowler, 2016) and to draw from existing cognitive test sets in comparable fields of
study (e.g. Charlton et al., 2009; Salthouse, 2011).
2.3. Topic (3): Treatment and care of older adults
2.3.1. Key questions
The discussion raised several issues relating to treatment pathways, care plans and the measurement of outcomes and the effect of
co-existing conditions and long-term medication use on life course outcomes. The primary question that emerged from this discussion
topic was: 'Which aspect(s) of physical and mental health intervention need to be addressed in ASD?' and a related question: 'What are the
effects of psychopharmacology and overuse of medication in autistic adults as they grow older?'.
2.3.2. Challenges to address question(s) and potential solution(s)
The main challenges identified centred on the life expectancy of older autistic adults, increased risk of mental health problems and
suicidality, and ASD-related co-existing conditions including epilepsy and ID which are related to cognitive and behavioural diffi-
culties in adulthood (Howlin et al., 2014; Totsika et al., 2010). These issues highlight the need for effective health care management
across the lifespan and raise the importance of understanding health-related effects on cognitive decline and increased risk of de-
mentia in later life (Croen et al., 2015; and see Howlin & Moss, 2012; Michael, 2016). A suggested potential first step towards a
solution was to make an inventory of all the interventions different countries have already successfully implemented so these can be
adapted to fit local needs and health care systems.
2.4. Possible ways for the autism research community to address the issues raised in the SIG
Across the three discussion topics – later life diagnosis, cognitive function/decline in aging, and treatment and care of older
adults, there was considerable overlap in the issues raised. Furthermore, two issues consistently featured as factors that are currently
hindering the progress of research on aging and ASD. These issues are: (i) identification of the core questions and factors that need to
be addressed on aging and ASD; and (ii) developing support for studies through collaboration and sharing of resources to achieve
more effective research outcomes. Delegates agreed that a centralised database would better facilitate collaborations between re-
searchers, practitioners, and the autism community. Such a database might include information about research protocols,
Table 1
Surveys results regarding the use of applied measures of ASD, background information and wellbeing in research with older autistic adults.
Domain Measures Survey responses Countriesa
Nstudies = 21 UK NL USA AU
ASD traits SRS-2 15 x x x
AQ 9 x x x
SCQ 5 x x
Other1 12 x x x x
Background questions Age (birth date) 22 x x x x
Gender (birth; identity) 22 x x x x
Age of diagnosis 20 x x x x
Living situation 19 x x x
Employment status 19 x x x x
Medication use 19 x x x x
Education level 18 x x x x
Other diagnosis now or in the past 18 x x x x
Relationship status 15 x x x x
Other2 21 x x x x
Well-being/Quality of Life WHOQOL-BREF 15 x x x x
Other3 17 x x x x
Notes: SRS-2: Social Responsiveness Scale–Second Edition (Constantino & Gruber, 2012; Constantino et al., 2003).
AQ: Autism Spectrum Quotient (Baron-Cohen et al., 2001).
SCQ: Social Communication Questionnaire (Rutter et al., 2003).
WHOQOL-BREF: World Health Organisation Quality of Life assessment–Short Form (WHOQOL Group, 1998).
1 TAS-20 (Toronto Alexithymia Scale; Bagby et al., 1994); SSQ (Sensory Sensitivity Questionnaire; Minshew & Hobson, 2008); IRI (Interpersonal
Reactivity Index; Davis, 1983).
2 Impact of ASD diagnosis, alcohol/drug use, diagnoses in family members, history of dementia/Alzheimer’s disease/Parkinson’s disease in family
members, current motor coordination issues, social network/support system (e.g. Croen et al., 2015).
3 PWI-A (Personal Wellbeing Index–Adult version; Cummins, 2002); WEMBS (Warwick & Edinburgh Mental Well-Being Scale; Tennant et al.,
2007); Quality of Life Questionnaire (Schalock & Keith, 1993).
a Respondents were from international research groups in the following countries (cities): UK (England: Cambridge; Newcastle; London);
Netherlands (Amsterdam); USA (Virginia; Arizona; North Carolina; Pennsylvania; Wisconsin; California; Georgia; Utah; Washington State;
Missouri); Australia (New South Wales; Victoria).
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methodologies and recent research findings. A centralised resource could also facilitate an increase in research participation by
making studies accessible to individuals across a range of abilities and locations. Such data pooling would need to comply with
General Data Protection Regulations (GDPR; Information Commissioner’s Office, 2018).
3. Post-SIG developments
The discussions from topics addressed during the first SIG raised several primary questions which were taken up at a special
meeting, which was held at Newcastle University in November 2016. There, a subgroup of researchers, practitioners and autistic
advocates convened to discuss further the theme of how to ensure the sharing of information and effective approaches to data
collection, internationally (UK, Netherlands, USA, Australia). As a result, a survey was developed in order to gain a more complete
view of the measures that are currently being used in research on old age in ASD. The survey encompassed three domains that
emerged from the first SIG meeting, regarding: (i) the measurement of ASD traits in older adults; (ii) how to obtain comprehensive
background developmental and medical history; and (iii) measuring wellbeing and quality of life across the lifespan. This survey was
emailed to 78 individuals, who took part in the first SIG and the subsequent Newcastle meeting, including the six large cohort studies
of older autistic adults (d’arc initiative, The Netherlands; The Ageing with Autism Project, United Kingdom; Adult Autism Spectrum
Cohort-UK, United Kingdom; and ongoing research projects in UK, Australia and USA). The survey data formed the basis of dis-
cussions at the second SIG meeting, which was held at INSAR San Francisco, USA in May 2017. The meeting was attended by 53
delegates from 12 countries (UK, Netherlands, Denmark, Sweden, Norway, Italy, USA, Canada, Argentina, Australia, Taiwan, Korea).
Subsequently, a further post-SIG survey was circulated to ensure that other researchers and practitioners who were collecting data on
old age ASD could add information about the measures they used in their studies. The findings from these discussion groups and the
two surveys are presented in Table 1, together with a breakdown of measures used in each region.
3.1. ASD traits in older adults
According to the survey responses, the most commonly used diagnostic screening measures were the Autism Quotient (AQ; Baron-
Cohen et al., 2001; Hoekstra et al., 2008; Hoekstra et al., 2011) and the Social Responsiveness Scale–Second Edition (SRS-2;
Constantino et al., 2003; Constantino & Gruber, 2012; and see Bölte et al., 2008; Bölte, 2012). Most studies included at least one of
these measures (AQ Nstudies = 9; SRS-2 Nstudies = 15), while some studies included both measures (Nstudies= 6). Other measures were
used (see Table 1) but these were often specific to a single study. Both the AQ and SRS-2 have advantages and disadvantages. The AQ
is freely available in a wide range of languages (e.g. Wakabayashi et al., 2006; Hoekstra et al., 2008). Although the SRS-2 is not free of
charge, it is available in many languages (e.g. Bölte, 2012) and contains more detail on the social domain. However, it is not known
how valid they are with an older population or how sensitive they are in measuring change across the life span. Recent evidence
suggests that co-existing mental health conditions, such as anxiety, may mediate the sensitivity of the SRS-2 in reliably detecting
autistic traits (South et al., 2017). One other measure, the Social Communication Questionnaire (SCQ; Rutter et al., 2003), was used
in several studies (Nstudies = 5). The SCQ is available in various languages but is not free of charge and presents similar challenges to
the AQ and SRS-2. In addition, there are currently no ASD diagnostic tools or screening instruments that solve the problem of
gathering information on early development (Wigham et al., 2018), or include normative data for those over 55 years of age. A
potential solution regarding normative data for older adults is to share data across research groups, as is done in other areas of
research (e.g. the Advanced Neuropsychological Diagnostics Infrastructure, ANDI; de Vent et al., 2016). We suggest a similar fra-
mework for pooled data to establish norms in ASD aging research, and as a potential approach to the management of data collection
and reporting of results. Furthermore, there was a consensus that information is also needed from autistic adults themselves, about
their lived experiences of the diagnostic process and the impact of their diagnosis.
3.2. Background information, diagnostic and medical history and cognitive assessment
Given that the primary interest was in aging, it was considered important to check the familial history of neurodegenerative
disorders such as dementia and Parkinson’s disease. Regarding the measures of ASD traits and other background information, dis-
cussions focusing on the reliance on self and/or other (i.e., caregiver) report are continuing. Many of the ongoing studies on aging and
ASD (identified in the SIG discussions and survey responses), reported the inclusion of individuals who are cognitively able to
complete self-report questionnaires. Consequently, several of the measures suggested above are less appropriate for those individuals
with an intellectual disability.
In this discussion group, some cognitive measures were discussed which align with the previous SIG (2016) discussions. Overall,
regarding the cognitive measures, there was less consensus between the research groups since the nature of cognitive assessment is
typically driven by specific research aims. It was acknowledged that clear methodological differences exist between the types of
cognitive assessments available in terms of the domains of measurement, and the administration methods (e.g. paper and pencil;
computerised). Consequently, more work is needed to explore the utility of specific cognitive measures for use with older adults
across both the autism spectrum and the range of intellectual ability usually found in the autistic population.
3.3. Well-being and quality of life
Regarding the measurement of well-being/quality of life most studies included the short form World Health Organisation Quality
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of Life Assessment (WHOQOL-BREF, WHOQOL Group, 1998; Skevington et al., 2004; Mason et al., 2018; for an overview of well-
being measures, see Ayres et al., 2017). A recent study also showed that this measure can be used successfully with autistic in-
dividuals although some items might be interpreted differently (McConachie et al., 2017). In order to overcome this difficulty,
additional autism-specific items have been developed (McConachie et al., 2017). One of the benefits of the WHOQOL-BREF is that it
has been used in a wide range of groups and is available free of charge in many languages. More importantly, it asks about the
individual’s satisfaction with life domains rather than making assumptions about the value of specific aspects of life. In this way,
normative assumptions (e.g. about having a range of friends) are not hindering measuring the autistic perspective. As mentioned
earlier, discussions about the appropriateness of measures have emphasised that questionnaires need to be ability- and age-range
inclusive and sensitive to change across the lifespan. For example, the Personal Well-being Index (PWI; Cummins, 2002) has a
separate version for individuals with an intellectual disability (Cummins & Lau, 2005). Moreover, the choice of which measures to use
is guided by the research focus – is the measure being used for comparative purposes or for service-oriented purposes?
4. Discussion
Several outcomes have emerged in the two-year period encompassing the SIG and Newcastle meetings. First, the programme of
meetings ensured that, for the first time, a broadly representative international group of researchers, practitioners, and autistic
advocates came together to discuss on-going work on aging and ASD, which may not as yet be published. Whereas, previous literature
has broadly conceptualised the gaps in knowledge with respect to aging and autism, this paper outlines the progress in research that
is currently being undertaken around the world and the key issues associated with that and future work. Second, several key
questions were identified through these discussions, which need to be addressed in future research. These were:
1 What questions should be asked to obtain appropriate background information about medical and developmental histories in older autistic
adults?
2 How do we define the core assessments of basic cognitive function that are appropriate for autistic individuals across the spectrum of ability
and across the lifespan?
3 Which aspects of co-existing conditions and mental health intervention need to be addressed in ASD?
4 What are the effects of psychopharmacology and overuse of medication in autistic adults as they grow older?
The third outcome was related to convergence about which measures can be easily accessed and administered with high reliability
and specificity, particularly associated with diagnosis of older autistic adults, mental health and well-being, and quality of life.
Although for measures used to establish a clinical picture of ASD no consensus was reached, the majority of studies include those
listed in Table 1. By contrast, clear consensus topics emerged for the background questions, with the important qualification that the
exact wording of these questions be formulated in collaboration with autistic adults. Regarding quality of life and well-being, the
WHOQOL-BREF is used in so many different studies that a collaborative data-sharing project in this area seems, in the short-term, to
be the most feasible.
A fourth outcome extended the discussions from the SIG meetings to further research workshops and symposia on aging and
autism. These include a one-day research seminar, titled ‘Ageing and Autism Spectrum Disorder: Life course changes, well-being and
service needs in later life.’, which was held at City, University of London, in July 2017. The seminar brought together autistic adults,
professionals, clinicians, support services, researchers and charitable organisations (N=70) to discuss quality of life, mental health
and cognitive changes in later life and the strategies for supporting the most pressing needs of autistic adults as they grow older. A
related meeting was held at Newcastle University, in September 2017, which set out to develop research priorities for aging and
autism in relation to specific areas of physical and mental health and well-being (Warner et al., 2018). In addition, in Canada, in
October 2017 there was an international meeting ‘Aging in later life: A Think Tank on the Effects of Aging on the Autism Spectrum,
which focused on similar topics as in the SIGs (i.e. understanding aging, supporting autistic adults, research methodologies and
outcome measures; see Autism Canada, 2017).
Finally, through the networks established from this SIG we identified the cross-sectional and longitudinal work that is ongoing on
aging and autism (Braden et al., 2017; Lever & Geurts, 2015; Powell et al., 2017; Roestorf, Howlin et al., 2018) and the potential for
multi-site collaborations to take this work forward.
4.1. Implications and future directions
The topics raised in this SIG propose important directions for future research on aging and autism, through engagement with the
autism community and collaborative research efforts. An important step, which is already undertaken in some countries, is to include
representatives of the autistic community who contribute to research design and interpretation and dissemination of findings. A key
aim for research partnerships is better to understand the challenges associated with assessment of older adults. Future work should
include a systematic review of the measures that are being used in aging ASD research. This knowledge would inform the devel-
opment of better diagnostic approaches to later life assessments, earlier referral for diagnosis, and establishing post-diagnostic
support pathways for autistic adults across the adult life course. Indeed, some of these issues have been captured as priorities for
aging and autism research in a recent report by Autistica (2018), whilst the focus of these topics seems aligned with emerging
research from recent studies on gender-differences in cognitive measures (Mandy & Lai, 2017), diagnostic differences in older age
(Lever & Geurts, 2018; Powell et al., 2017; Roestorf, Gaigg et al., 2018), and ASD-relevant measures of quality of life (Mason et al.,
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2018; McConachie et al., 2017; Moss et al., 2017).
Future research efforts encompassing multi-site studies that use a combination of cross-sectional and longitudinal methods would
enhance research knowledge in: (a) our understanding of typical and atypical aging in ASD; and (b) the relative effectiveness of
intervention approaches for different sub-groups of older autistic adults. Longitudinal follow-up studies of autistic adults across the
lifespan and programmatic research that involves large scale data collections and analysis would drive more rapid progress in our
understanding of the issues raised in this paper. Furthermore, combined research efforts and improved methodological approaches
would potentially inform the supports and interventions that enable autistic adults to lead fulfilling and rewarding lives.
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